Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the shares of the company are sold short. Based on […]